List
Overview
Speakers
Type
Full screen
Days
Speakers
Session Type
Search
Full screen
Sat 18 May 2019
Sat 18
Sun 19 May 2019
Sun 19
Mon 20 May 2019
Mon 20
Tue 21 May 2019
Tue 21
All
List
At A Glance
Speaker list
Categories
Posters
List
List
Type
Diabetes, Obesity and Metabolism
Adrenal and Neuroendocrine Tumours
Thyroid
Interdisciplinary Endocrinology
PEM1
PL2
Reproductive Endocrinology
OC1
Environmental, Society and Governance
Calcium and Bone
Pituitary and Neuroendocrinology
Organ cross-talk in endocrine disease
Hub 1.6
No focus area
Workshop
Oral
Expert
Plenary
Catering and Social
Nurse
Other
Symposium
Not specified
Hide all
Show all
Saturday 18 May
7 sessions
09:00 - 17:00
Pre-congress Courses
12:00 - 20:00
REGISTRATION
17:00 - 17:45
ECE 2019 Opening Ceremony
L'Amphithéâtre
17:45 - 18:15
Plenary: Geoffrey Harris Award Lecture
L'Amphithéâtre
Chairs: AJ van der Lely (The Netherlands) & Monica Marazuela (Spain)
17:45
GH1
Translational research in pituitary disease
Günter Stalla
18:20 - 18:50
Plenary: European Journal of Endocrinology Award Lecture
L'Amphithéâtre
Chairs: Wiebke Arlt (UK) & AJ van der Lely (The Netherlands)
18:20
EJE1
New approaches in the differential diagnosis of Diabetes insipidus
Mirjam Christ-Crain
(Basel, Switzerland)
19:00 - 19:30
Plenary 1
L'Amphithéâtre
Chairs: Marta Korbonits (UK) & Sebastian Neggers (The Netherlands)
19:00
PL1
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
Avi Friedman
19:30 - 20:45
Welcome Reception
Exhibition area
Sunday 19 May
45 sessions
07:00 - 18:00
REGISTRATION
08:00 - 08:40
Meet The Expert 1: Diabetes, Obesity and Metabolism
Forum 3
Diabetes, Obesity and Metabolism
08:00
MTE1
The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
Christophe Block
08:00 - 08:40
Meet The Expert 2: Diabetes, Obesity and Metabolism
Auditorium Lumière
Diabetes, Obesity and Metabolism
08:00
MTE2
Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
Roberto Vettor
08:00 - 08:40
Meet The Expert 3: Adrenal and Neuroendocrine Tumours
Forum 2
Adrenal and Neuroendocrine Tumours
08:00
MTE3
The management of primary aldosteronism
Andrzej Januszewicz
08:00 - 08:40
Meet The Expert 4: Adrenal and Neuroendocrine Tumours
Salle Gratte-Ciel 1+2+3
Adrenal and Neuroendocrine Tumours
08:00
MTE4
Management of a life-long disease in CAH
Nicole Reisch
(Munich, Germany)
08:00 - 08:40
Meet The Expert 5: Thyroid
L'Amphithéâtre
Thyroid
08:00
MTE5
Risk classification of thyroid nodules by ultrasound and indications for FNA
Laurence Leenhardt
08:00 - 08:40
Meet The Basic Scientist 1: Interdisciplinary Endocrinology
Forum 1
Interdisciplinary Endocrinology
08:00
MTBS1
New tracers for PET in humans and rodents: Hopes, aims and current evidence
Lars Gormsen
08:00 - 08:45
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Salon Prestige Gratte Ciel
Chairs: AJ van der Lely (The Netherlands) & Andrea Giustina (Italy)
PEM1
08:00
PEM1.1
Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
Andrea Giustina
08:05
PEM1.2
The clinical view of Endocrinology in Europe
Jerome Bertherat
(France)
08:15
PEM1.3
The research view of Endocrinology in Europe
Felix Beuschlein
(Zürich, Switzerland)
08:25
PEM1.4
The early-career perspective
Anneke Beukel
08:35
PEM1.5
Closing remarks and discussion
Andrea Giustina
08:50 - 09:20
Interview with the ESE President and President-Elect
L'Amphithéâtre
09:20 - 09:50
Plenary 2
ENDORSED BY: EJE (European Journal of Endocrinology)
L'Amphithéâtre
Chairs: Manuel Tena-Sempere (Spain) & Csilla Krausz (Italy)
PL2
09:20
PL2
Genetic epidemiology of puberty timing and reproductive lifespan
Ken Ong
(Cambridge, United Kingdom)
09:50 - 10:20
Tea & Coffee
Exhibition area
10:20 - 11:50
Symposium 1: Thyroid in cancer
Forum 3
Chairs: Barbara Jarzab (Poland) & Sophie Leboulleux (France)
Thyroid
10:20
S1.1
What is the value of molecular markers in nodules
Laura Fugazzola
10:50
S1.2
Iodine refractoriness in thyroid cells
Chris McCabe
(UK, Birmingham)
11:20
S1.3
New paradigms in the treatment of low risk thyroid cancer
Martin Schlumberger
10:20 - 11:50
Symposium 2: Trends in Puberty
Forum 2
Chairs: Carlo Acerini (UK) & Vincent Prevot (France)
Reproductive Endocrinology
10:20
S2.1
Exploring the Epigenetic Landscape of Puberty
Alejandro Lomniczi
10:50
S2.2
Endocrine disruptors in puberty
Anne-Simone Parent
(Liège, Belgium))
11:20
S2.3
Genetic basis in puberty
Sasha Howard
(London, UK)
10:20 - 11:50
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Salle Gratte-Ciel 1+2+3
Chairs: Ashley Grossman (UK) & Gudmundur Johannsson (Sweden)
Interdisciplinary Endocrinology
10:20
S3.1
Circadian control of glucocorticoid function
David Ray
(Manchester, UK)
10:50
S3.2
Fixing the Broken Clock in Adrenal Disorders
Andrea Isidori
11:20
S3.3
Light Up Your Sex Life!
Takashi Yoshimura
10:20 - 11:50
Symposium 4: Immunology and endocrinology
ENDORSED BY: EC (Endocrine Connections)
Forum 1
Chairs: Sandra Pekic (Serbia) & Simon Pearce (UK)
Interdisciplinary Endocrinology
10:50
S4.2
Clinical: Immunotherapy and endocrine disease
Maria Stelmachowska-Banas
11:00
S4.3
Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
Olle Kämpe
11:20
S4.1
Basic: Immunotherapy and endocrine disease
Patrizio Caturegli
10:20 - 11:50
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
L'Amphithéâtre
Chairs: Anton Luger (Austria) & Ioannis Androulakis (Greece)
Diabetes, Obesity and Metabolism
10:20
S5.1
Human gut microbiome: hopes, threats and promises
Hubert Vidal
10:50
S5.2
Fecal transplantation: Myth or reality
Max Nieuwdorp
11:20
S5.3
Targeted Microbiome Intervention for handling insulin resistance
Matthias Laudes
10:20 - 11:50
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Auditorium Lumière
Chairs: AJ van der Lely (The Netherlands) & Jenny Visser (The Netherlands) & Andre Lacroix (Canada)
10:20
SS1.1
Obesity gives you cancer: the bigger picture!
Jeff Holly
10:50
SS1.2
Sleep Deficiency: A Pathway to Obesity
Erin Hanlon
11:20
SS1.3
Social economic impact of the globesity pandemic
Felipe Casanueva
10:20 - 11:50
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Salon Prestige Gratte-Ciel
Chairs: Niki Karavitaki (UK) & Chona Feliciano (UK)
10:20
NS1.1
Overview of Immunotherapy: Indications and adverse effects
Christelle Fouchardiere
10:55
NS1.2
Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
Daniel Morganstein
11:30
NS1.3
The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
Sherwin Criseno
(Birmingham, UK)
12:00 - 13:00
Controversies Session: Food addiction in humans: to be or not to be?
L'Amphithéâtre
Chairs: Uberto Pagotto (Italy) & Gatta-Cherifi Blandine (France)
Interdisciplinary Endocrinology
12:00
C1.1
Food addiction in humans: to be or not to be?
Fernando Fernandez-Aranda
12:00 - 13:00
ESE Council of Affiliated Societies Session
Auditorium Lumiere
Chairs: Djuro Macut (Serbia) & Bulent Yildiz (Turkey)
12:00
ECAS1.1
Mapping Endocrinology in Europe - ECAS report
Djuro Macut
12:20
ECAS1.2
Centres of special interest - how could we move on?
George Mastorakos
12:40
ECAS1.3
3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
Bulent Yildiz
12:00 - 13:00
Oral Communications 1: Calcium and Bone
Salle Gratte-Ciel 1+2+3
Chairs: Lars Rejnmark (Denmark) & Peter Kamenicky (France)
OC1
12:00
OC1.1
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
Ruth Casey
(Cambridge, United Kingdom)
12:12
OC1.2
Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
Federica Saponaro
12:24
OC1.3
MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
Sabrina Corbetta
12:36
OC1.4
Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
Kristina Chen
12:48
OC1.5
Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
Heide Siggelkow
12:00 - 13:00
Nurses Session 2: Meet the Nurse Expert
Salon Prestige Gratte-Ciel
Chairs: Sherwin Criseno (UK) & Janina Sauerwald (Germany)
12:00
MTNE1
Nursing Approach To The Holistic Care of Patients with Intellectual Disability
Ruth Northway
12:00 - 13:00
Oral Communications 2: Diabetes 1
Forum 2
Chairs: Hubert Vidal (France) & Bruno Verges (France)
12:00
OC2.1
EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
Sari Mäkimattila
12:12
OC2.2
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
Qiaoran Liu
12:24
OC2.3
Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
Chiranjit Ghosh
12:36
OC2.4
Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
Narjes Nasiri-Ansari
12:48
OC2.5
5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
Shelley Harris
12:00 - 13:00
Oral Communications 3: Cushing's and acromegaly
Forum 1
Chairs: Ansgar Heck (Norway) & Marianne Andersen (Denmark)
12:00
OC3.1
Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
Rosario Pivonello
12:12
OC3.2
Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
Athanasios Fountas
12:24
OC3.3
Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
Jiang-Ning Zhou
12:36
OC3.4
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
Mai Arlien-Søborg
12:48
OC3.5
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
Eva Coopmans
12:00 - 13:00
Oral Communications 4: Thyroid 2
Forum 3
Chairs: Bernard Goichot (France) & James Hennessey (USA)
12:00
OC4.1
Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
Marta Astigarraga
12:12
OC4.2
Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
Meir Frankel
12:24
OC4.3
PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
Nadia Bouzehouane
12:36
OC4.4
Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
Paul Sibilia
12:48
OC4.5
A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
Romana Netea-Maier
13:00 - 15:00
Lunch & Poster viewing
Exhibition area
13:00 - 13:45
Nurses Textbook Launch, Lunch and Informal Networking
ECE Hub
13:45 - 14:45
Industry Sponsored Satellite Symposium
Forum 2
13:45 - 14:45
Industry Sponsored Satellite Symposium
Forum 1
13:45 - 14:45
Industry Sponsored Satellite Symposium
Salle Gratte-Ciel 1+2+3
14:00 - 14:45
New Scientific Approach 1
Forum 3
Chair: Matti Poutanen (Finland)
14:00
NSA1
Steroidomics
Stefan Wudy
(Giessen, Germany)
14:00 - 14:45
New Scientific Approach 2
Auditorium Lumière
Chair: Agnieszka Piekielko-Witkowska (Poland)
14:00
NSA2
Single cell spatial reconstruction of endocrine organs
Keren Halpern
15:00 - 16:30
Symposium 6: A better life with thyroid hormone
ENDORSED BY: EJE (European Journal of Endocrinology)
L'Amphithéâtre
Chairs: Emese Mezosi (Hungary) & Ulla Feldt-Rasmussen (Denmark)
Thyroid
15:00
S6.1
Prediction of the thyroid axis set-point
Marco Medici
15:30
S6.2
Subclinical hypothyroidism in children
Maria Salerno
16:00
S6.3
Subclinical hypothyroidism in the elderly
Simon Pearce
(Newcastle, UK)
15:00 - 16:30
Symposium 7: Endocrine Disrupting Chemicals
ENDORSED BY: EC (Endocrine Connections)
Forum 3
Chairs: Josef Koehrle (Germany) & Anne-Simone Parent (Belgium)
Environmental, Society and Governance
15:00
S7.1
Endocrine Disrupting Chemicals and Thyroid
Jean Fini
15:30
S7.2
Endocrine Disrupting Chemicals and Diabetes Mellitus
Angel Nadal
16:00
S7.3
Endocrine Disrupting Chemicals and Obesity
Bruce Blumberg
15:00 - 16:30
Symposium 8: Gender dysphoria
Salle Gratte-Ciel 1+2+3
Chairs: Feyza Darendeliler (Turkey) & Luca Persani (Italy)
Interdisciplinary Endocrinology
15:00
S8.1
Psychoendocrinology Of Gender Dysphoria
Emmanuele Jannini
15:30
S8.2
Gender Dysphoria –management of puberty
Martine Cools
(Gent, Belgium)
16:00
S8.3
Gender reassignment surgery in dysphoria
Nicolas Morel-Journel
15:00 - 16:30
Symposium 9: Controversies in adrenal disease
Forum 2
Chairs: Judith Favier (France) & Daniel Olsson (Sweden)
Adrenal and Neuroendocrine Tumours
15:00
S9.3
Is there a role for subtotal adrenalectomy
Radu Mihai
15:30
S9.1
Metanephrines - plasma or urine?
Graeme Eisenhofer
16:00
S9.2
The do's and don'ts of genetic testing in phaeochromocytoma
Mercedes Robledo
15:00 - 16:30
Symposium 10: Cancer drug-induced osteoporosis
ENDORSED BY: EC (Endocrine Connections)
Forum 1
Chairs: Martine Cohen-Solal (France) & Carola Zillikens (The Netherlands)
Calcium and Bone
15:00
S10.1
Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
Martina Rauner
(Dresden, Germany)
15:30
S10.2
Aromatase inhibitors and bone
Carola Zillikens
16:00
S10.3
TSH-suppressive therapy and bone
Claudio Marcocci
15:00 - 17:00
Nurses Session 3: Professional Development
Salon Prestige Gratte-Ciel
Chairs: Sofia Llahana (UK) & Sherwin Criseno (UK)
15:00
NPD1.1
Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
Sofia Llahana
(London, UK)
15:30
NPD1.2
2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
Anna Hawkins
15:45
NPD1.5
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
Chris Yedinak
(USA), Lisa Shepherd)
15:45
NDP1.4
Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
Houaria Chanson
15:45
NPD1.3
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
Sofia Llahana
(London, UK)
15:15 - 16:30
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
Auditorium Lumière
Chairs: Massimo Mannelli (Italy) & Frederic Castinetti (France)
Adrenal and Neuroendocrine Tumours
15:15
D1.1
FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
Henri Timmers
(Nijmegen, The Netherlands)
15:15
D1.2
AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
Martin Walz
(Essen, Germany)
16:30 - 17:00
Tea & Coffee
Exhibition area
17:00 - 17:30
Plenary 3
L'Amphithéâtre
Chairs: Bulent Yildiz (Turkey) & Anton Luger (Austria)
17:00
PL3
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Susan Bonner-Weir
17:45 - 19:15
Industry Sponsored Satellite Symposium
Forum 1
17:45 - 19:15
Industry Sponsored Satellite Symposium
Forum 2
17:45 - 19:15
Industry Sponsored Satellite Symposium
Salle Gratte-Ciel 1+2+3
19:30 - 23:00
Informal Networking Evening
(Badge holders only)
Monday 20 May
41 sessions
07:00 - 18:00
REGISTRATION
08:00 - 08:40
Meet The Expert 6: Calcium and Bone
Forum 3
Calcium and Bone
08:00
MTE6
Primary Hyperparathyroidism: Surgical vs Medical Therapy
Tomaz Kocjan
08:00 - 08:40
Meet The Expert 7: Pituitary and Neuroendocrinology
L'Amphithéâtre
Pituitary and Neuroendocrinology
08:00
MTE7
Non functional Pituitary Tumours - not always easy
Davide Carvalho
08:00 - 08:40
Meet The Expert 8: Reproductive Endocrinology
Auditorium Lumière
Reproductive Endocrinology
08:00
MTE8
Co-morbidities in Turner syndrome
Claus Gravholt
08:00 - 08:40
Meet The Expert 9: Reproductive Endocrinology
Forum 2
Reproductive Endocrinology
08:00
MTE9
Co-morbidities in Klinefelter syndrome
Anne Skakkebæk
08:00 - 08:40
Meet The Expert 10: Reproductive Endocrinology
Forum 1
Reproductive Endocrinology
08:00
MTE10
NCAH and Female reproduction
Eda Ertorer
08:00 - 08:40
Meet The Basic Scientist 2
Salle Gratte-Ciel 1+2+3
08:00
MTBS2
Genetically tailored pig models in translational endocrine and metabolic research
Eckhard Wolf
08:50 - 09:20
Plenary 4
L'Amphithéâtre
Chairs: Camilla Schalin-Jäntti (Finland) & Beata Kos-Kulda (Poland)
08:50
PL4
Exercise training in the management of T2D
Juleen Zierath
09:20 - 09:50
Plenary: European Hormone Medal Lecture
L'Amphithéâtre
Chairs: Djuro Macut (Serbia) & Andrea Giustina (Italy)
09:20
EHM1
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
Jens Bollerslev
09:50 - 10:20
Tea & Coffee
Exhibition area
10:20 - 11:20
Debate 2: T4 is not enough
L'Amphithéâtre
Chairs: Robin Peeters (The Netherlands) & Patrice Rodien (France)
Thyroid
10:20
D2.2
AGAINST: No, T4 is enough
James Hennessey
10:20
D2.1
FOR: Yes, T4 is not enough
Birte Nygaard
10:20 - 11:50
Symposium 11: EDCs and reproduction
Forum 3
Chairs: Rachel Desailloud (France) & Anna-Maria Andersson (Denmark)
Environmental, Society and Governance
10:20
S11.1
Oocytes, Pesticides and IVF
Moncef Benkhalifa
10:50
S11.2
Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
Patrick Fénichel
11:20
S11.3
Mitigating against endocrine disruption in pregnancy
Katharina Main
10:20 - 11:50
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
Forum 1
Chairs: Michael Buchfelder (Germany) & Cesar Boguszewski (Brazil)
Pituitary and Neuroendocrinology
10:20
S12.1
The view of the surgeon: When, how much and when to refrain from surgery?
Stephanie Puget
10:50
S12.2
New potential treatment alternatives in patients with papillary craniopharyngioma
Tareq Juratli
11:20
S12.3
How to manage the long-term consequences of hypothalamic damages
Eva- Erfurth
10:20 - 11:50
Symposium 13: Central Control of Metabolism: Brain rules all
Salle Gratte-Ciel 1+2+3
Chairs: Johannes Romijn (The Netherlands) & Ivana Kraljevic (Croatia)
Diabetes, Obesity and Metabolism
10:20
S13.1
All optics in the metabolic brain
J. Betley
10:50
S13.2
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
Marc Claret
11:20
S13.3
Genetics of appetite regulation
Giles Yeo
(Cambridge, UK)
10:20 - 11:50
Symposium 14: Innovations in NETs
Auditorium Lumière
Chairs: Diego Ferone (Italy) & Mehtap Cakir (Turkey)
Adrenal and Neuroendocrine Tumours
10:20
S14.1
Innovative imaging of insulinoma: The end of sampling…
Emanuel Christ
10:50
S14.2
A role for radionuclide therapy for high-grade NETs
Halfdan Sorbye
11:20
S14.3
Fishing for NETs
Giovanni Vitale
10:20 - 11:50
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Forum 2
Chairs: Peter Aldiss (UK) & Thomas Cuny (France)
Organ cross-talk in endocrine disease
10:20
S15.1
Welcome and Introduction to EYES
Peter Aldiss
10:25
S15.2
Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
Andrea Lovdel
10:45
S15.3
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Ashley Castellanos
11:05
S15.4
The role and cross-talk between incretin hormones and occurrence of Nonalcoholic steatohepatitis
Benjamin Bouillet
11:25
S15.5
Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome
Beata Malachowska
11:45
S15.6
Closing remarks
Thomas Cuny
10:20 - 12:05
Nurses Session 4: Parathyroid Disorders
Salon Prestige Gratte-Ciel
Chairs: Zaki Hassan-Smith (UK) & Maria Pedersen (Sweden)
10:20
NPD2.1
Hypoparathyroidism: Aetiology, diagnosis and challenges in management
Ansgar Heck
10:55
NPD2.2
Hyperparathyroidism: Evidence-based screening and management
Rachel Crowley
(Dublin, Ireland)
11:30
NPD2.3
Parathyroid Surgery: Indications and Consequences
Jean Lifante
12:00 - 13:00
Debate 3: Pituitary Pathology: Do we care?
L'Amphithéâtre
Chairs: Gerald Raverot (France) & Jens Otto Jorgensen (Denmark)
Pituitary and Neuroendocrinology
12:00
D3.1
FOR: Yes, we care about pituitary pathology
Olivera Casar-Borota
12:00
D3.2
AGAINST: No, we don't care about pituitary pathology
Sven Schlaffer
12:00 - 13:00
Oral Communications 8: Reproduction 1
Forum 1
Chairs: Victor Navarro (USA) & Nadine Binart (France)
12:00
OC8.1
Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse
Delphine Franssen
12:12
OC8.2
AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients
Lucie Renault
12:24
OC8.3
Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus.
David Rodriguez
12:36
OC8.4
Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH Neurons Reveals Specific Roles in Reproductive and Metabolic Homeostasis
Juan Rivas
12:48
OC8.5
The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: Responder Analysis Results From a Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
Graeme Fraser
12:00 - 13:00
Oral Communications 9: Thyroid 1
Auditorium Lumière
Chairs: Clara Alvarez (Spain) & Patrice Rodien (France)
12:00
OC9.1
3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism
Jorge García-Giménez
12:12
OC9.2
Direct evidence for disulfides in the mechanism of deiodinase 1
Ulrich Schweizer
12:24
OC9.3
Novel driver mutations in thyroid cancer recurrence
Hannah Nieto
(Birmingham, United Kingdom)
12:36
OC9.4
Resistance to thyroid hormone alpha associated with early-onset severe NASH
Valentina Pautasso
12:48
OC9.5
Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models.
Yasmine Kemkem
12:00 - 13:00
Oral Communications 5: Adrenal 2
Forum 3
Chairs: Francoise Borson Chazot (France) & Felix Beuschlein (Switzerland)
12:00
OC5.1
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma
Alexandre Buffet
12:12
OC5.2
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
Elena Rapizzi
12:24
OC5.3
SF3B1 as novel target for the treatment of multiple endocrine-related cancers
Juan Jiménez-Vacas
12:36
OC5.4
The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
Sergio Pedraza-Arévalo
12:48
OC5.5
Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
Andrea Widmer
12:00 - 13:00
Oral Communications 6: Obesity 1
Forum 2
Chairs: Giles Yeo (UK) & Blandine Gatta-Cherifi (France)
12:00
OC6.1
Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
Michael Culler
12:12
OC6.2
Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
Anna Ferrulli
12:24
OC6.3
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Ashley Castellanos
12:36
OC6.4
Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
Arnaud Jannin
12:48
OC6.5
Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
Michal Meron
12:00 - 13:00
Oral Communications 7: Endocrine Connections
Salle Gratte-Ciel 1+2+3
Chairs: Corin Badiu (Romania) & Marie-Christine Vantyghem (France)
12:00
OC7.1
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
Carmen Aresta
12:12
OC7.2
Thyroid hormones are new key regulators of glucocorticoid metabolism
Laura Bessiène
12:24
OC7.3
HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
Volha Zhukouskaya
12:36
OC7.4
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
Anne Barlier
12:48
OC7.5
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
Linda Humbert
13:00 - 15:00
Lunch & Poster viewing
Exhibition area
13:00 - 14:00
ESE President meets new members
13:00 - 14:00
Nurses Poster Viewing and Presentations, Lunch and Informal Networking
Salon Prestige Gratte-Ciel
13:00 - 13:45
Endo-ERN Session - Lunch Hub
ECE Hub
13:00
ERN1.1
Introduction and update on Endo-ERN
Alberto Arias
13:01
ERN1.2
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Lars Rejnmark
13:02
ERN1.3
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Danielle Steenvoorden
13:45 - 14:45
Industry Sponsored Satellite Symposium
Forum 2
13:45 - 14:45
Industry Sponsored Satellite Symposium
Forum 3
13:45 - 14:45
Industry Sponsored Satellite Symposium
Auditorium Lumière
14:00 - 14:45
New Scientific Approach 3
Salle Gratte-Ciel 1+2+3
Chair: Guillaume Assie (France)
14:00
NSA3
Intelligent image based in situ single cell isolation
Gabor Tamas
14:00 - 14:45
New Scientific Approach 4
Forum 1
Chair: Vera Popovic (Serbia)
14:00
NSA4
When will AI take over from the endocrinologist?
Anca Bucur
15:00 - 16:30
Symposium 16: Thyroid in pregnancy
L'Amphithéâtre
Chairs: Sophie Christin-Maitre (France) & Leonidas Duntas (Greece)
Thyroid
15:00
S16.1
Thyroid autoimmunity and fertility
David Unuane
15:30
S16.2
Thyroid disease and pregnancy outcomes
Fereidoun Azizi
16:00
S16.3
Thyroid disease and offspring development
Deborah Levie
15:00 - 16:30
Symposium 17: Where Do Pituitary Tumours Come From
Forum 1
Chairs: Günter K. Stalla (Germany) & Philippe Chanson (France)
Pituitary and Neuroendocrinology
15:00
S17.1
Specification of cell fate
Jacques Drouin
15:30
S17.2
Pertubations in novel signalling pathways
Cynthia Andoniadou
(London, UK)
16:00
S17.3
From Lab to Clinic - Can we translate into effective therapeutics
Peter Kamenicky
15:00 - 16:30
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Salle Gratte-Ciel 1+2+3
Chairs: Ursula Kaiser (USA) & Nelly Pitteloud (Switzerland)
Reproductive Endocrinology
15:00
S18.1
GnRH migration and vomeronasal neurons
Paolo Forni
15:30
S18.2
Flipping the GnRH switch with microRNAs
Andrea Messina
16:00
S18.3
Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
Jacques Young
15:00 - 16:30
Symposium 19: Adrenal Insufficiency
Forum 2
Chairs: Antoine Tabarin (France) & Thierry Brue (France)
Adrenal and Neuroendocrine Tumours
15:00
S19.1
New insights into autoimmune adrenal insufficiency
Eystein Husebye
15:30
S19.2
Long-term results of slow acting glucocorticoids - are they really better?
Gudmundur Johannsson
16:00
S19.3
Optimising care delivery in Congenital Adrenal Hyperplasia
Nils Krone
15:00 - 16:30
Symposium 20: News on Nutrition: When to eat what
Forum 3
Chairs: Bruno Verges (France) & Justo Castaño (Spain)
Diabetes, Obesity and Metabolism
15:00
S20.1
Precision Nutrition for managing obesity – Does it work?
Carlos Celis-Morales
15:30
S20.2
Is limiting the timing of food intake a viable nutritional approach?
Denise Robertson
16:00
S20.3
PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
Emilio Ros
15:00 - 16:30
Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
Auditorium Lumière
Chair: Michel Pugeat (France)
15:00
GS1
Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
Renato Santini
16:50 - 17:20
Plenary: Clinical Endocrinology Trust Lecture
L'Amphithéâtre
Chairs: Jerome Bertherat (France) & Wiebke Arlt (UK)
16:50
CET1
How can patients perception of outcome be improved after controlling pituitary disease?
Susan Webb
(Barcelona, Spain)
17:20 - 17:50
Plenary 5
L'Amphithéâtre
Chairs: Felix Beuschlein (Germany) & Françoise Borson-Chazot (France)
17:20
PL5
Paracrine regulation of the adrenal cortex
Hervé Lefebvre
18:00 - 19:30
Industry Sponsored Satellite Symposium
Salle Gratte-Ciel 1+2+3
Tuesday 21 May
38 sessions
07:00 - 17:30
REGISTRATION
08:00 - 08:40
Meet The Expert 11: Calcium and Bone
Forum 2
Calcium and Bone
08:00
MTE11
Shifting treatment paradigms in osteoporosis
Nuria Guanabens
08:00 - 08:40
Meet The Expert 12: Calcium and Bone
Forum 1
Calcium and Bone
08:00
MTE12
Fracture risk prediction in benign and tumoral bone: new insights
Cyrille Confavreux
08:00 - 08:40
Meet The Expert 13: Interdisciplinary Endocrinology
Forum 3
Interdisciplinary Endocrinology
08:00
MTE13
Flushing, blushing and sweating
Pierre Bouloux
08:00 - 08:40
Meet The Expert 14: Interdisciplinary Endocrinology
Salle Gratte-Ciel 1+2+3
Interdisciplinary Endocrinology
08:00
MTE14
How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
Laura Graaff
08:00 - 08:40
Meet The Expert 15: Pituitary and Neuroendocrinology
L'Amphithéâtre
Pituitary and Neuroendocrinology
08:00
MTE15
To what degree does hypopituitarism exist after TBI?
Marianne Klose
08:00 - 08:40
Meet The Expert 16: Interdisciplinary Endocrinology
Auditorium Lumière
Interdisciplinary Endocrinology
08:00
MTE16.2
Is it all in your head or just in the lab?
Martin Bidlingmaier
08:00
MTE16.1
Is it all in your head or just in the lab?
Julio Abucham
08:00 - 08:40
Meet The Basic Scientist 3
Salon Prestige Gratte-Ciel
08:00
MTBS3
The “Gravitostat” – How does it relate to hormones?
John-Olov Jansson
08:50 - 09:20
Plenary 6
L'Amphithéâtre
Chairs: Claudio Marcocci (Italy) & Jacque Orgiazzi (France)
08:50
PL6
Treatment strategies for Graves orbitopathy
George Kahaly
(Mianz, Germany)
09:20 - 09:50
Tea & Coffee
Exhibition area
09:50 - 10:50
Debate 4: MicroRNAs as hormones?
Salle Gratte-Ciel 1+2+3
Chairs: Peter Igaz (Hungary) & Attila Patócs (Hungary)
Interdisciplinary Endocrinology
09:50
D4.2
AGAINST: MicroRNAs as hormones?
Alberto Davalos
09:50
D4.1
FOR: MicroRNAs and extracellular vesicles as hormones?
Edit Buzás
09:50 - 11:20
Symposium 21: Rare Bone Disorders
Forum 2
Chairs: Barbara Obermayer-Pietsch (Austria) & Lars Rejmark (Denmark)
Calcium and Bone
09:50
S21.1
Animal model of bone fragility
Antonella Forlino
10:20
S21.2
New perspectives on the treatment of skeletal dysplasia
Valérie Cormier-Daire
(Paris, France)
10:50
S21.3
Osteogenesis imperfecta throughout life
Kassim Javaid
09:50 - 11:20
Symposium 22: The Pituitary As Metabolic Sensor
Forum 1
Chairs: Clara Alvarez (Spain) & Agnieszka Baranowska-Bik (Poland)
Pituitary and Neuroendocrinology
09:50
S22.1
Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
Victor Navarro
10:20
S22.2
How treatments with endocrine & metabolic drugs influence pituitary cell function?
Giovanni Tulipano
10:50
S22.3
Bidirectional interrelationship between growth hormone and metabolism
Raul Luque
09:50 - 11:20
Symposium 23: PCOS: Can we personalise treatment?
Auditorium Lumière
Chairs: Marija Pfeifer (Slovenia) & Terhi Piltonen (Finland)
Reproductive Endocrinology
09:50
S23.1
Gut brain axis
María Insenser
10:20
S23.2
Implicating androgen excess in metabolic disease in PCOS
Unknown speaker
10:50
S23.3
Treatment options in cardiometabolic PCOS phenotype
Mojca Sever
09:50 - 11:20
Symposium 24: What's new in the Adrenal Cortex?
ENDORSED BY: EJE (European Journal of Endocrinology)
Forum 3
Chairs: Darko Kastelan (Croatia) & Marc Lombes (France)
Adrenal and Neuroendocrine Tumours
09:50
S24.1
New genes, new understanding, new therapy
Guillaume Assie
10:20
S24.2
Primary hyperaldosteronism: does our treatment work?
Tracy Williams
10:50
S24.3
Autonomous cortisol secretion has cardiovascular consequences
Iacopo Chiodini
09:50 - 11:20
Symposium 25: Late breaking
L'Amphithéâtre
Chairs: Sebastian Neggers (The Netherlands) & Manuel Tena-Sempere (Spain)
09:50
S25.1
Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
Guadalupe Sabio
10:20
S25.2
LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
Rima Smith
10:50
S25.3
Maternal smoking and high BMI disrupt thyroid gland development
Panagiotis Filis
09:50 - 11:20
Publishing Session
Salon Prestige Gratte-Ciel
Chair: Beata Kos-Kulda (Poland)
09:50
PS1.1
Endocrine Connections - ‘Increase the visibility of your research: open access and more’
Josef Koehrle
10:20
PS1.2
EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
Gesthimani Mintziori
10:50
PS1.3
European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
Olaf Dekkers
11:30 - 12:30
Oral Communications 10: Adrenal 1
Forum 2
Chairs: Attila Patocs (Hungary) & Jerome Bertherat (France)
11:30
OC10.1
Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
Elizabeth Baranowski
11:42
OC10.2
Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
Géraldine Vitellius
11:54
OC10.3
Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
Anna Vaczlavik
12:06
OC10.4
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Isadora Cavalcante
12:18
OC10.5
Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
Cristina Ronchi
(Birmingham, United Kingdom)
11:30 - 12:30
UEMS Session
Forum 3
Chairs: Maeve Durkan (Republic of Ireland) & Teri Brouwer (The Netherlands)
11:30
UEMS1.2
Update on European Exam in Endocrinology
Graham Roberts
11:45
UEMS1.1
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
Maeve Durkan
12:00
UEMS1.3
The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
Mirela Ilie
11:30 - 12:30
Oral Communications 11: Diabetes 2
Auditorium Lumière
Chairs: Philippe Moulin (France) & Colin Duncan (UK)
11:30
OC11.1
Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
Sopio Tatulashvili
11:42
OC11.2
Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
David Selva
11:54
OC11.3
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
Hye Chung
12:06
OC11.4
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
Daisy Crispim
12:18
OC11.5
Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
Mariasara Persano
11:30 - 12:30
Oral Communications 12: Endocrine Connections 2
Salle Gratte-Ciel 1+2+3
Chairs: Patric Delhanty (The Netherlands) & Paolo Beck-Peccoz (Italy)
11:30
OC12.1
Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
Elizabeth Winter
11:42
OC12.2
Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
Laurence Dumeige
11:54
OC12.3
Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
Prudencio Sáez-Martínez
12:06
OC12.4
Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
Emilie Merlen
12:18
OC12.5
Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
Justine Defreyne
11:30 - 12:30
Oral Communcations 13: Anteria and posteria pituitary
Forum 1
Chairs: Mirjam Christ-Crain (Sweden) & Charlotte Højby (Sweden)
11:30
OC13.1
Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
Bettina Winzeler
11:42
OC13.2
Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
Julie Refardt
11:54
OC13.3
Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
Pedro Marques
12:06
OC13.4
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
Birgitte Damholt
12:18
OC13.5
Pan-genomic classification of Pituitary Adenomas
Mario Neou
11:30 - 12:30
Oral Communications 14: Sex Hormones
Salon Prestige Gratte-Ciel
Chairs: Ilpo Huhtaniemi (Finland) & Michel Pugeat (France)
11:30
OC14.1
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
Giulia Rastrelli
11:42
OC14.2
The effect of testosterone therapy on serum oestradiol levels in transgender men
Justine Defreyne
11:54
OC14.3
First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
Isabelle Beau
12:06
OC14.4
Thyroid diseases in Danish women with polycystic ovary syndrome.
Dorte Glintborg
12:18
OC14.5
The pattern of cancer occurrence in Turner syndrome
Claus Gravholt
12:30 - 14:30
Lunch & Poster viewing
Exhibition area
12:45 - 13:30
ESE Annual General Meeting
13:00 - 13:45
EU research funding - overview of opportunities and insights towards a successful application
ECE HUB - Exhibition area
Chairs: Felix Beuschlein (Switzerland) & Valerie Handweiler (France)
Hub 1.6
13:30 - 14:15
New Scientific Approach 5
Forum 1
Chair: Cristina Olarescu (Norway)
13:30
NSA5
Genome-wide effects of vitamin D on chromatin
Carsten Carlberg
13:30 - 14:15
New Scientific Approach 6
Forum 2
Chair: Patrice Mollard (France)
13:30
NSA6
Brain imaging in conscious mice
Pauline Campos
14:30 - 15:30
Debate 5: Should we treat young osteoporotic patients
L'Amphithéâtre
Chairs: Gesthimani Mintziori (Greece) & Carola Zillikens (The Netherlands)
Calcium and Bone
14:30
D5.2
AGAINST: No, we shouldn't treat young osteoporotic patients
Barbara Obermayer-Pietsch
14:30
D5.1
FOR: Yes, we should treat young osteoporotic patients
Serge Ferrari
14:30 - 16:00
Symposium 26: Impact of thyroid disease on...
Auditorium Lumière
Chairs: Marek Ruchala (Poland) & Leonidas Duntas (Greece)
Thyroid
14:30
S26.1
Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
Bernard Lerer
15:00
S26.2
Bone
Graham Williams
15:30
S26.3
Cardiac hypertrophy
Maria Barreto-Chaves
14:30 - 16:00
Symposium 27: What's new in reproductive endocrinology?
Forum 1
Chairs: Jenny Visser (The Netherlands) & Sophie Christin-Maitre (France)
Reproductive Endocrinology
14:30
S27.1
Dissecting Androgens in PCOS
Kirsty Walters
15:00
S27.2
Large scale genetic studies in male infertility
Frank Tuttelmann
15:30
S27.3
Menopause and cardiovascular risk
Irene Lambrinoudaki
14:30 - 16:00
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Salle Gratte-Ciel 1+2+3
Chairs: Bruno Lapauw (Belgium) & Nuria Guanabens (Spain)
Calcium and Bone
14:30
S28.1
Vitamin D and its metabolites
Elisabeth Winter
15:00
S28.2
Vitamin D and Type 1 Diabetes
Suvi Virtanen
15:30
S28.3
How and when to measure Vitamin D
Jean Souberbielle
14:30 - 16:00
Symposium 29: Endocrine controversies in sport
Forum 2
Chairs: Margaret Boguszewski (Brazil) & Martin Bidlingmaier (Germany)
Environmental, Society and Governance
14:30
S29.1
Female hyperandrogenism and elite sport
Angelica Hirschberg
(Stockholm, Sweden)
15:00
S29.2
Performance enhancing drugs in young males
Pim Ronde
15:30
S29.3
Omics to fight doping
Guan Wang
14:30 - 16:00
Symposium 30: Personalised medicine in diabetes and obesity
ENDORSED BY: EJE (European Journal of Endocrinology)
Forum 3
Chairs: Philippe Moulin (France) & Anneke van den Beukel (The Netherlands)
Diabetes, Obesity and Metabolism
14:30
S30.1
Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
Dale Abel
15:00
S30.2
New avenues for novel drugs to treat obesity
John Wilding
(Liverpool, United Kingdom)
15:30
S30.3
Curing diabetes with alternatives: bariatric surgery
Jochen Seufert
16:00 - 16:30
Tea & Coffee
Exhibition area
16:30 - 17:00
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
L'Amphithéâtre
Chairs: Manuel Tena-Sempere (Spain) & Sebastian Neggers (The Netherlands) & Françoise Borson-Chazot (France)
EYIJC1
The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
Esben Søndergaard
EYIJC2
Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
Miguel López
17:00 - 17:30
Plenary 7
L'Amphithéâtre
Chairs: Riccarda Granata (Italy) & Daniela Cota (France)
17:00
PL7
Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
Jens Brüning
17:30 - 17:45
Closing Ceremony
L'Amphithéâtre
Elena Rapizzi
OC5.2
Mon 20
12:00
Oral Communications 5: Adrenal 2
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
Juan Jiménez-Vacas
OC5.3
Mon 20
12:00
Oral Communications 5: Adrenal 2
SF3B1 as novel target for the treatment of multiple endocrine-related cancers
Sergio Pedraza-Arévalo
OC5.4
Mon 20
12:00
Oral Communications 5: Adrenal 2
The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
Andrea Widmer
OC5.5
Mon 20
12:00
Oral Communications 5: Adrenal 2
Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
Michael Culler
OC6.1
Mon 20
12:00
Oral Communications 6: Obesity 1
Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
Anna Ferrulli
OC6.2
Mon 20
12:00
Oral Communications 6: Obesity 1
Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
Arnaud Jannin
OC6.4
Mon 20
12:00
Oral Communications 6: Obesity 1
Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
Michal Meron
OC6.5
Mon 20
12:00
Oral Communications 6: Obesity 1
Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
Carmen Aresta
OC7.1
Mon 20
12:00
Oral Communications 7: Endocrine Connections
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
Laura Bessiène
OC7.2
Mon 20
12:00
Oral Communications 7: Endocrine Connections
Thyroid hormones are new key regulators of glucocorticoid metabolism
Volha Zhukouskaya
OC7.3
Mon 20
12:00
Oral Communications 7: Endocrine Connections
HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
Anne Barlier
OC7.4
Mon 20
12:00
Oral Communications 7: Endocrine Connections
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
Linda Humbert
OC7.5
Mon 20
12:00
Oral Communications 7: Endocrine Connections
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
Alberto Arias
ERN1.1
Mon 20
13:00
Endo-ERN Session - Lunch Hub
Introduction and update on Endo-ERN
Lars Rejnmark
ERN1.2
Mon 20
13:00
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Danielle Steenvoorden
ERN1.3
Mon 20
13:00
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Gabor Tamas
NSA3
Mon 20
14:00
New Scientific Approach 3
Intelligent image based in situ single cell isolation
Anca Bucur
NSA4
Mon 20
14:00
New Scientific Approach 4
When will AI take over from the endocrinologist?
David Unuane
S16.1
Mon 20
15:00
Symposium 16: Thyroid in pregnancy
Thyroid autoimmunity and fertility
Fereidoun Azizi
S16.2
Mon 20
15:00
Symposium 16: Thyroid in pregnancy
Thyroid disease and pregnancy outcomes
Deborah Levie
S16.3
Mon 20
15:00
Symposium 16: Thyroid in pregnancy
Thyroid disease and offspring development
Jacques Drouin
S17.1
Mon 20
15:00
Symposium 17: Where Do Pituitary Tumours Come From
Specification of cell fate
Cynthia Andoniadou
S17.2
Mon 20
15:00
Symposium 17: Where Do Pituitary Tumours Come From
Pertubations in novel signalling pathways
Peter Kamenicky
S17.3
Mon 20
15:00
Symposium 17: Where Do Pituitary Tumours Come From
From Lab to Clinic - Can we translate into effective therapeutics
Paolo Forni
S18.1
Mon 20
15:00
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
GnRH migration and vomeronasal neurons
Andrea Messina
S18.2
Mon 20
15:00
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Flipping the GnRH switch with microRNAs
Jacques Young
S18.3
Mon 20
15:00
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
Eystein Husebye
S19.1
Mon 20
15:00
Symposium 19: Adrenal Insufficiency
New insights into autoimmune adrenal insufficiency
Gudmundur Johannsson
S19.2
Mon 20
15:00
Symposium 19: Adrenal Insufficiency
Long-term results of slow acting glucocorticoids - are they really better?
Carlos Celis-Morales
S20.1
Mon 20
15:00
Symposium 20: News on Nutrition: When to eat what
Precision Nutrition for managing obesity – Does it work?
Denise Robertson
S20.2
Mon 20
15:00
Symposium 20: News on Nutrition: When to eat what
Is limiting the timing of food intake a viable nutritional approach?
Emilio Ros
S20.3
Mon 20
15:00
Symposium 20: News on Nutrition: When to eat what
PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
Renato Santini
GS1
Mon 20
15:00
Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
Susan Webb
CET1
Mon 20
16:50
Plenary: Clinical Endocrinology Trust Lecture
How can patients perception of outcome be improved after controlling pituitary disease?
Hervé Lefebvre
PL5
Mon 20
17:20
Plenary 5
Paracrine regulation of the adrenal cortex
Nuria Guanabens
MTE11
Tue 21
08:00
Meet The Expert 11: Calcium and Bone
Shifting treatment paradigms in osteoporosis
Cyrille Confavreux
MTE12
Tue 21
08:00
Meet The Expert 12: Calcium and Bone
Fracture risk prediction in benign and tumoral bone: new insights
Laura Graaff
MTE14
Tue 21
08:00
Meet The Expert 14: Interdisciplinary Endocrinology
How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
Marianne Klose
MTE15
Tue 21
08:00
Meet The Expert 15: Pituitary and Neuroendocrinology
To what degree does hypopituitarism exist after TBI?
Martin Bidlingmaier
MTE16.2
Tue 21
08:00
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Julio Abucham
MTE16.1
Tue 21
08:00
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
John-Olov Jansson
MTBS3
Tue 21
08:00
Meet The Basic Scientist 3
The “Gravitostat” – How does it relate to hormones?
George Kahaly
PL6
Tue 21
08:50
Plenary 6
Treatment strategies for Graves orbitopathy
Alberto Davalos
D4.2
Tue 21
09:50
Debate 4: MicroRNAs as hormones?
AGAINST: MicroRNAs as hormones?
Edit Buzás
D4.1
Tue 21
09:50
Debate 4: MicroRNAs as hormones?
FOR: MicroRNAs and extracellular vesicles as hormones?
Antonella Forlino
S21.1
Tue 21
09:50
Symposium 21: Rare Bone Disorders
Animal model of bone fragility
Valérie Cormier-Daire
S21.2
Tue 21
09:50
Symposium 21: Rare Bone Disorders
New perspectives on the treatment of skeletal dysplasia
Victor Navarro
S22.1
Tue 21
09:50
Symposium 22: The Pituitary As Metabolic Sensor
Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
Giovanni Tulipano
S22.2
Tue 21
09:50
Symposium 22: The Pituitary As Metabolic Sensor
How treatments with endocrine & metabolic drugs influence pituitary cell function?
Raul Luque
S22.3
Tue 21
09:50
Symposium 22: The Pituitary As Metabolic Sensor
Bidirectional interrelationship between growth hormone and metabolism
María Insenser
S23.1
Tue 21
09:50
Symposium 23: PCOS: Can we personalise treatment?
Gut brain axis
Mojca Sever
S23.3
Tue 21
09:50
Symposium 23: PCOS: Can we personalise treatment?
Treatment options in cardiometabolic PCOS phenotype
Guillaume Assie
S24.1
Tue 21
09:50
Symposium 24: What's new in the Adrenal Cortex?
New genes, new understanding, new therapy
Tracy Williams
S24.2
Tue 21
09:50
Symposium 24: What's new in the Adrenal Cortex?
Primary hyperaldosteronism: does our treatment work?
Iacopo Chiodini
S24.3
Tue 21
09:50
Symposium 24: What's new in the Adrenal Cortex?
Autonomous cortisol secretion has cardiovascular consequences
Guadalupe Sabio
S25.1
Tue 21
09:50
Symposium 25: Late breaking
Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
Rima Smith
S25.2
Tue 21
09:50
Symposium 25: Late breaking
LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
Panagiotis Filis
S25.3
Tue 21
09:50
Symposium 25: Late breaking
Maternal smoking and high BMI disrupt thyroid gland development
Josef Koehrle
PS1.1
Tue 21
09:50
Publishing Session
Endocrine Connections - ‘Increase the visibility of your research: open access and more’
Gesthimani Mintziori
PS1.2
Tue 21
09:50
Publishing Session
EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
Olaf Dekkers
PS1.3
Tue 21
09:50
Publishing Session
European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
Elizabeth Baranowski
OC10.1
Tue 21
11:30
Oral Communications 10: Adrenal 1
Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
Géraldine Vitellius
OC10.2
Tue 21
11:30
Oral Communications 10: Adrenal 1
Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
Anna Vaczlavik
OC10.3
Tue 21
11:30
Oral Communications 10: Adrenal 1
Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
Isadora Cavalcante
OC10.4
Tue 21
11:30
Oral Communications 10: Adrenal 1
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Graham Roberts
UEMS1.2
Tue 21
11:30
UEMS Session
Update on European Exam in Endocrinology
Maeve Durkan
UEMS1.1
Tue 21
11:30
UEMS Session
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
Mirela Ilie
UEMS1.3
Tue 21
11:30
UEMS Session
The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
Sopio Tatulashvili
OC11.1
Tue 21
11:30
Oral Communications 11: Diabetes 2
Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
David Selva
OC11.2
Tue 21
11:30
Oral Communications 11: Diabetes 2
Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
Hye Chung
OC11.3
Tue 21
11:30
Oral Communications 11: Diabetes 2
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
Daisy Crispim
OC11.4
Tue 21
11:30
Oral Communications 11: Diabetes 2
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
Mariasara Persano
OC11.5
Tue 21
11:30
Oral Communications 11: Diabetes 2
Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
Elizabeth Winter
OC12.1
Tue 21
11:30
Oral Communications 12: Endocrine Connections 2
Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
Laurence Dumeige
OC12.2
Tue 21
11:30
Oral Communications 12: Endocrine Connections 2
Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
Prudencio Sáez-Martínez
OC12.3
Tue 21
11:30
Oral Communications 12: Endocrine Connections 2
Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
Emilie Merlen
OC12.4
Tue 21
11:30
Oral Communications 12: Endocrine Connections 2
Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
Justine Defreyne
OC12.5
Tue 21
11:30
Oral Communications 12: Endocrine Connections 2
Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
Justine Defreyne
OC14.2
Tue 21
11:30
Oral Communications 14: Sex Hormones
The effect of testosterone therapy on serum oestradiol levels in transgender men
Bettina Winzeler
OC13.1
Tue 21
11:30
Oral Communcations 13: Anteria and posteria pituitary
Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
Julie Refardt
OC13.2
Tue 21
11:30
Oral Communcations 13: Anteria and posteria pituitary
Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
Pedro Marques
OC13.3
Tue 21
11:30
Oral Communcations 13: Anteria and posteria pituitary
Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
Birgitte Damholt
OC13.4
Tue 21
11:30
Oral Communcations 13: Anteria and posteria pituitary
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
Mario Neou
OC13.5
Tue 21
11:30
Oral Communcations 13: Anteria and posteria pituitary
Pan-genomic classification of Pituitary Adenomas
Giulia Rastrelli
OC14.1
Tue 21
11:30
Oral Communications 14: Sex Hormones
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
Isabelle Beau
OC14.3
Tue 21
11:30
Oral Communications 14: Sex Hormones
First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
Dorte Glintborg
OC14.4
Tue 21
11:30
Oral Communications 14: Sex Hormones
Thyroid diseases in Danish women with polycystic ovary syndrome.
Claus Gravholt
OC14.5
Tue 21
11:30
Oral Communications 14: Sex Hormones
The pattern of cancer occurrence in Turner syndrome
Carsten Carlberg
NSA5
Tue 21
13:30
New Scientific Approach 5
Genome-wide effects of vitamin D on chromatin
Pauline Campos
NSA6
Tue 21
13:30
New Scientific Approach 6
Brain imaging in conscious mice
Barbara Obermayer-Pietsch
D5.2
Tue 21
14:30
Debate 5: Should we treat young osteoporotic patients
AGAINST: No, we shouldn't treat young osteoporotic patients
Serge Ferrari
D5.1
Tue 21
14:30
Debate 5: Should we treat young osteoporotic patients
FOR: Yes, we should treat young osteoporotic patients
Bernard Lerer
S26.1
Tue 21
14:30
Symposium 26: Impact of thyroid disease on...
Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
Maria Barreto-Chaves
S26.3
Tue 21
14:30
Symposium 26: Impact of thyroid disease on...
Cardiac hypertrophy
Kirsty Walters
S27.1
Tue 21
14:30
Symposium 27: What's new in reproductive endocrinology?
Dissecting Androgens in PCOS
Frank Tuttelmann
S27.2
Tue 21
14:30
Symposium 27: What's new in reproductive endocrinology?
Large scale genetic studies in male infertility
Irene Lambrinoudaki
S27.3
Tue 21
14:30
Symposium 27: What's new in reproductive endocrinology?
Menopause and cardiovascular risk
Elisabeth Winter
S28.1
Tue 21
14:30
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and its metabolites
Suvi Virtanen
S28.2
Tue 21
14:30
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and Type 1 Diabetes
Jean Souberbielle
S28.3
Tue 21
14:30
Symposium 28: Vitamin D - non-skeletal effects in RCTs
How and when to measure Vitamin D
Pim Ronde
S29.2
Tue 21
14:30
Symposium 29: Endocrine controversies in sport
Performance enhancing drugs in young males
Guan Wang
S29.3
Tue 21
14:30
Symposium 29: Endocrine controversies in sport
Omics to fight doping
Dale Abel
S30.1
Tue 21
14:30
Symposium 30: Personalised medicine in diabetes and obesity
Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
Jochen Seufert
S30.3
Tue 21
14:30
Symposium 30: Personalised medicine in diabetes and obesity
Curing diabetes with alternatives: bariatric surgery
Esben Søndergaard
EYIJC1
Tue 21
16:30
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
Miguel López
EYIJC2
Tue 21
16:30
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
Jens Brüning
PL7
Tue 21
17:00
Plenary 7
Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
Mirjam Christ-Crain
EJE1
Sat 18
18:20
Plenary: European Journal of Endocrinology Award Lecture
New approaches in the differential diagnosis of Diabetes insipidus
John Wilding
S30.2
Tue 21
14:30
Symposium 30: Personalised medicine in diabetes and obesity
New avenues for novel drugs to treat obesity
Hannah Nieto
OC9.3
Mon 20
12:00
Oral Communications 9: Thyroid 1
Novel driver mutations in thyroid cancer recurrence
Giles Yeo
S13.3
Mon 20
10:20
Symposium 13: Central Control of Metabolism: Brain rules all
Genetics of appetite regulation
Rachel Crowley
NPD2.2
Mon 20
10:20
Nurses Session 4: Parathyroid Disorders
Hyperparathyroidism: Evidence-based screening and management
Felix Beuschlein
PEM1.3
Sun 19
08:00
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The research view of Endocrinology in Europe
Nils Krone
S19.3
Mon 20
15:00
Symposium 19: Adrenal Insufficiency
Optimising care delivery in Congenital Adrenal Hyperplasia
Sasha Howard
S2.3
Sun 19
10:20
Symposium 2: Trends in Puberty
Genetic basis in puberty
Angelica Hirschberg
S29.1
Tue 21
14:30
Symposium 29: Endocrine controversies in sport
Female hyperandrogenism and elite sport
Martine Cools
S8.2
Sun 19
15:00
Symposium 8: Gender dysphoria
Gender Dysphoria –management of puberty
Ken Ong
PL2
Sun 19
09:20
Plenary 2
Genetic epidemiology of puberty timing and reproductive lifespan
Stefan Wudy
NSA1
Sun 19
14:00
New Scientific Approach 1
Steroidomics
Anne-Simone Parent
S2.2
Sun 19
10:20
Symposium 2: Trends in Puberty
Endocrine disruptors in puberty
Kassim Javaid
S21.3
Tue 21
09:50
Symposium 21: Rare Bone Disorders
Osteogenesis imperfecta throughout life
Ruth Casey
OC1.1
Sun 19
12:00
Oral Communications 1: Calcium and Bone
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
Cristina Ronchi
OC10.5
Tue 21
11:30
Oral Communications 10: Adrenal 1
Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
David Ray
S3.1
Sun 19
10:20
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Circadian control of glucocorticoid function
Daniel Morganstein
NS1.2
Sun 19
10:20
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
Martin Schlumberger
S1.3
Sun 19
10:20
Symposium 1: Thyroid in cancer
New paradigms in the treatment of low risk thyroid cancer
Chris McCabe
S1.2
Sun 19
10:20
Symposium 1: Thyroid in cancer
Iodine refractoriness in thyroid cells
Pierre Bouloux
MTE13
Tue 21
08:00
Meet The Expert 13: Interdisciplinary Endocrinology
Flushing, blushing and sweating
Graham Williams
S26.2
Tue 21
14:30
Symposium 26: Impact of thyroid disease on...
Bone
Günter Stalla
GH1
Sat 18
17:45
Plenary: Geoffrey Harris Award Lecture
Translational research in pituitary disease
Avi Friedman
PL1
Sat 18
19:00
Plenary 1
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
Christophe Block
MTE1
Sun 19
08:00
Meet The Expert 1: Diabetes, Obesity and Metabolism
The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
Roberto Vettor
MTE2
Sun 19
08:00
Meet The Expert 2: Diabetes, Obesity and Metabolism
Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
Andrzej Januszewicz
MTE3
Sun 19
08:00
Meet The Expert 3: Adrenal and Neuroendocrine Tumours
The management of primary aldosteronism
Nicole Reisch
MTE4
Sun 19
08:00
Meet The Expert 4: Adrenal and Neuroendocrine Tumours
Management of a life-long disease in CAH
Laurence Leenhardt
MTE5
Sun 19
08:00
Meet The Expert 5: Thyroid
Risk classification of thyroid nodules by ultrasound and indications for FNA
Lars Gormsen
MTBS1
Sun 19
08:00
Meet The Basic Scientist 1: Interdisciplinary Endocrinology
New tracers for PET in humans and rodents: Hopes, aims and current evidence
Andrea Giustina
PEM1.1
Sun 19
08:00
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
Andrea Giustina
PEM1.5
Sun 19
08:00
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Closing remarks and discussion
Jerome Bertherat
PEM1.2
Sun 19
08:00
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The clinical view of Endocrinology in Europe
Anneke Beukel
PEM1.4
Sun 19
08:00
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The early-career perspective
Laura Fugazzola
S1.1
Sun 19
10:20
Symposium 1: Thyroid in cancer
What is the value of molecular markers in nodules
Alejandro Lomniczi
S2.1
Sun 19
10:20
Symposium 2: Trends in Puberty
Exploring the Epigenetic Landscape of Puberty
Andrea Isidori
S3.2
Sun 19
10:20
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Fixing the Broken Clock in Adrenal Disorders
Takashi Yoshimura
S3.3
Sun 19
10:20
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Light Up Your Sex Life!
Maria Stelmachowska-Banas
S4.2
Sun 19
10:20
Symposium 4: Immunology and endocrinology
Clinical: Immunotherapy and endocrine disease
Olle Kämpe
S4.3
Sun 19
10:20
Symposium 4: Immunology and endocrinology
Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
Patrizio Caturegli
S4.1
Sun 19
10:20
Symposium 4: Immunology and endocrinology
Basic: Immunotherapy and endocrine disease
Hubert Vidal
S5.1
Sun 19
10:20
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Human gut microbiome: hopes, threats and promises
Max Nieuwdorp
S5.2
Sun 19
10:20
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Fecal transplantation: Myth or reality
Matthias Laudes
S5.3
Sun 19
10:20
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Targeted Microbiome Intervention for handling insulin resistance
Jeff Holly
SS1.1
Sun 19
10:20
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Obesity gives you cancer: the bigger picture!
Erin Hanlon
SS1.2
Sun 19
10:20
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Sleep Deficiency: A Pathway to Obesity
Felipe Casanueva
SS1.3
Sun 19
10:20
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Social economic impact of the globesity pandemic
Christelle Fouchardiere
NS1.1
Sun 19
10:20
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Overview of Immunotherapy: Indications and adverse effects
Sherwin Criseno
NS1.3
Sun 19
10:20
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
Fernando Fernandez-Aranda
C1.1
Sun 19
12:00
Controversies Session: Food addiction in humans: to be or not to be?
Food addiction in humans: to be or not to be?
Djuro Macut
ECAS1.1
Sun 19
12:00
ESE Council of Affiliated Societies Session
Mapping Endocrinology in Europe - ECAS report
George Mastorakos
ECAS1.2
Sun 19
12:00
ESE Council of Affiliated Societies Session
Centres of special interest - how could we move on?
Bulent Yildiz
ECAS1.3
Sun 19
12:00
ESE Council of Affiliated Societies Session
3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
Federica Saponaro
OC1.2
Sun 19
12:00
Oral Communications 1: Calcium and Bone
Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
Sabrina Corbetta
OC1.3
Sun 19
12:00
Oral Communications 1: Calcium and Bone
MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
Kristina Chen
OC1.4
Sun 19
12:00
Oral Communications 1: Calcium and Bone
Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
Heide Siggelkow
OC1.5
Sun 19
12:00
Oral Communications 1: Calcium and Bone
Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
Ruth Northway
MTNE1
Sun 19
12:00
Nurses Session 2: Meet the Nurse Expert
Nursing Approach To The Holistic Care of Patients with Intellectual Disability
Sari Mäkimattila
OC2.1
Sun 19
12:00
Oral Communications 2: Diabetes 1
EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
Qiaoran Liu
OC2.2
Sun 19
12:00
Oral Communications 2: Diabetes 1
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
Chiranjit Ghosh
OC2.3
Sun 19
12:00
Oral Communications 2: Diabetes 1
Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
Narjes Nasiri-Ansari
OC2.4
Sun 19
12:00
Oral Communications 2: Diabetes 1
Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
Shelley Harris
OC2.5
Sun 19
12:00
Oral Communications 2: Diabetes 1
5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
Rosario Pivonello
OC3.1
Sun 19
12:00
Oral Communications 3: Cushing's and acromegaly
Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
Athanasios Fountas
OC3.2
Sun 19
12:00
Oral Communications 3: Cushing's and acromegaly
Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
Jiang-Ning Zhou
OC3.3
Sun 19
12:00
Oral Communications 3: Cushing's and acromegaly
Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
Mai Arlien-Søborg
OC3.4
Sun 19
12:00
Oral Communications 3: Cushing's and acromegaly
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
Eva Coopmans
OC3.5
Sun 19
12:00
Oral Communications 3: Cushing's and acromegaly
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
Marta Astigarraga
OC4.1
Sun 19
12:00
Oral Communications 4: Thyroid 2
Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
Meir Frankel
OC4.2
Sun 19
12:00
Oral Communications 4: Thyroid 2
Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
Nadia Bouzehouane
OC4.3
Sun 19
12:00
Oral Communications 4: Thyroid 2
PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
Paul Sibilia
OC4.4
Sun 19
12:00
Oral Communications 4: Thyroid 2
Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
Romana Netea-Maier
OC4.5
Sun 19
12:00
Oral Communications 4: Thyroid 2
A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
Keren Halpern
NSA2
Sun 19
14:00
New Scientific Approach 2
Single cell spatial reconstruction of endocrine organs
Marco Medici
S6.1
Sun 19
15:00
Symposium 6: A better life with thyroid hormone
Prediction of the thyroid axis set-point
Maria Salerno
S6.2
Sun 19
15:00
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in children
Simon Pearce
S6.3
Sun 19
15:00
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in the elderly
Jean Fini
S7.1
Sun 19
15:00
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Thyroid
Angel Nadal
S7.2
Sun 19
15:00
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Diabetes Mellitus
Bruce Blumberg
S7.3
Sun 19
15:00
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Obesity
Emmanuele Jannini
S8.1
Sun 19
15:00
Symposium 8: Gender dysphoria
Psychoendocrinology Of Gender Dysphoria
Nicolas Morel-Journel
S8.3
Sun 19
15:00
Symposium 8: Gender dysphoria
Gender reassignment surgery in dysphoria
Radu Mihai
S9.3
Sun 19
15:00
Symposium 9: Controversies in adrenal disease
Is there a role for subtotal adrenalectomy
Graeme Eisenhofer
S9.1
Sun 19
15:00
Symposium 9: Controversies in adrenal disease
Metanephrines - plasma or urine?
Mercedes Robledo
S9.2
Sun 19
15:00
Symposium 9: Controversies in adrenal disease
The do's and don'ts of genetic testing in phaeochromocytoma
Martina Rauner
S10.1
Sun 19
15:00
Symposium 10: Cancer drug-induced osteoporosis
Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
Carola Zillikens
S10.2
Sun 19
15:00
Symposium 10: Cancer drug-induced osteoporosis
Aromatase inhibitors and bone
Claudio Marcocci
S10.3
Sun 19
15:00
Symposium 10: Cancer drug-induced osteoporosis
TSH-suppressive therapy and bone
Sofia Llahana
NPD1.1
Sun 19
15:00
Nurses Session 3: Professional Development
Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
Sofia Llahana
NPD1.3
Sun 19
15:00
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
Anna Hawkins
NPD1.2
Sun 19
15:00
Nurses Session 3: Professional Development
2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
Chris Yedinak
NPD1.5
Sun 19
15:00
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
Houaria Chanson
NDP1.4
Sun 19
15:00
Nurses Session 3: Professional Development
Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
Henri Timmers
D1.1
Sun 19
15:15
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
Martin Walz
D1.2
Sun 19
15:15
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
Susan Bonner-Weir
PL3
Sun 19
17:00
Plenary 3
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Tomaz Kocjan
MTE6
Mon 20
08:00
Meet The Expert 6: Calcium and Bone
Primary Hyperparathyroidism: Surgical vs Medical Therapy
Davide Carvalho
MTE7
Mon 20
08:00
Meet The Expert 7: Pituitary and Neuroendocrinology
Non functional Pituitary Tumours - not always easy
Claus Gravholt
MTE8
Mon 20
08:00
Meet The Expert 8: Reproductive Endocrinology
Co-morbidities in Turner syndrome
Anne Skakkebæk
MTE9
Mon 20
08:00
Meet The Expert 9: Reproductive Endocrinology
Co-morbidities in Klinefelter syndrome
Eda Ertorer
MTE10
Mon 20
08:00
Meet The Expert 10: Reproductive Endocrinology
NCAH and Female reproduction
Eckhard Wolf
MTBS2
Mon 20
08:00
Meet The Basic Scientist 2
Genetically tailored pig models in translational endocrine and metabolic research
Juleen Zierath
PL4
Mon 20
08:50
Plenary 4
Exercise training in the management of T2D
Jens Bollerslev
EHM1
Mon 20
09:20
Plenary: European Hormone Medal Lecture
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
James Hennessey
D2.2
Mon 20
10:20
Debate 2: T4 is not enough
AGAINST: No, T4 is enough
Birte Nygaard
D2.1
Mon 20
10:20
Debate 2: T4 is not enough
FOR: Yes, T4 is not enough
Moncef Benkhalifa
S11.1
Mon 20
10:20
Symposium 11: EDCs and reproduction
Oocytes, Pesticides and IVF
Patrick Fénichel
S11.2
Mon 20
10:20
Symposium 11: EDCs and reproduction
Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
Katharina Main
S11.3
Mon 20
10:20
Symposium 11: EDCs and reproduction
Mitigating against endocrine disruption in pregnancy
Stephanie Puget
S12.1
Mon 20
10:20
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
The view of the surgeon: When, how much and when to refrain from surgery?
Tareq Juratli
S12.2
Mon 20
10:20
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
New potential treatment alternatives in patients with papillary craniopharyngioma
Eva- Erfurth
S12.3
Mon 20
10:20
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
How to manage the long-term consequences of hypothalamic damages
J. Betley
S13.1
Mon 20
10:20
Symposium 13: Central Control of Metabolism: Brain rules all
All optics in the metabolic brain
Marc Claret
S13.2
Mon 20
10:20
Symposium 13: Central Control of Metabolism: Brain rules all
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
Emanuel Christ
S14.1
Mon 20
10:20
Symposium 14: Innovations in NETs
Innovative imaging of insulinoma: The end of sampling…
Halfdan Sorbye
S14.2
Mon 20
10:20
Symposium 14: Innovations in NETs
A role for radionuclide therapy for high-grade NETs
Giovanni Vitale
S14.3
Mon 20
10:20
Symposium 14: Innovations in NETs
Fishing for NETs
Peter Aldiss
S15.1
Mon 20
10:20
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Welcome and Introduction to EYES
Andrea Lovdel
S15.2
Mon 20
10:20
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
Ashley Castellanos
S15.3
Mon 20
10:20
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Ashley Castellanos
OC6.3
Mon 20
12:00
Oral Communications 6: Obesity 1
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Benjamin Bouillet